MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals

Share Price and Basic Stock Data

Last Updated: July 30, 2025, 11:18 am

Market Cap	663 Cr.
Current Price	1,725
High / Low	2,400/1,151
Stock P/E	70.7
Book Value	267
Dividend Yield	0.06 %
ROCE	16.5 %
ROE	9.56 %
Face Value	10.0
PEG Ratio	2.53

Quick Insight

MKVentures Capital Ltd, currently trading at ₹1,725 with a market capitalization of ₹663 crore, presents a mixed financial picture. The high P/E ratio of 70.7 suggests that investors are willing to pay a premium for future growth, but this is tempered by a concerning operating profit margin (OPM) of -230.90%. The return on equity (ROE) of 9.56% and return on capital employed (ROCE) of 16.5% indicate moderate efficiency in generating profits from equity and capital, respectively. With no borrowings and a robust interest coverage ratio (ICR) of 5.19x, MKVentures is financially stable. However, the low promoter holding of 74.36% and lack of institutional investment (FIIs at 4.26%) may raise concerns about long-term confidence. Investors should weigh these factors carefully, especially the negative OPM, before making investment decisions.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for

Competitors of

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MKVentures Capital Ltd	663 Cr.	1,725	2,400/1,151	70.7	267	0.06 %	16.5 %	9.56 %	10.0
Modern Shares & Stockbrokers Ltd	12.5 Cr.	42.8	67.7/36.4	56.9	43.5	0.00 %	3.32 %	1.74 %	10.0
Monarch Networth Capital Ltd	2,948 Cr.	372	501/280	19.1	102	0.14 %	33.3 %	26.1 %	10.0
Monotype India Ltd	47.1 Cr.	0.67	2.42/0.65	4.58	0.02	0.00 %	286 %	%	1.00
Multipurpose Trading & Agencies Ltd	5.16 Cr.	10.4	13.3/8.25	30.4	10.3	0.00 %	4.44 %	3.91 %	10.0
Industry Average	6,794.81 Cr	1,428.46		80.99	3,733.88	0.37%	21.18%	13.30%	7.34

All Competitor Stocks of

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.28	0.13	2.66	14.03	10.47	12.59	9.60	8.44	8.41	7.65	6.82	7.86	2.88
Expenses	0.26	0.00	0.05	0.16	1.38	0.83	0.78	0.61	0.61	0.50	0.45	0.48	9.53
Operating Profit	0.02	0.13	2.61	13.87	9.09	11.76	8.82	7.83	7.80	7.15	6.37	7.38	-6.65
OPM %	7.14%	100.00%	98.12%	98.86%	86.82%	93.41%	91.88%	92.77%	92.75%	93.46%	93.40%	93.89%	-230.90%
Other Income	-0.01	0.00	0.03	0.03	0.00	0.18	0.43	1.16	0.61	0.45	0.66	0.68	0.53
Interest	0.00	0.00	0.24	1.58	2.18	4.48	2.76	2.06	0.48	0.54	1.28	0.83	0.57
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.06	0.09	0.09	0.10	0.09
Profit before tax	0.01	0.13	2.40	12.32	6.91	7.46	6.49	6.91	7.87	6.97	5.66	7.13	-6.78
Tax %	-1,900.00%	0.00%	26.25%	25.08%	25.18%	27.08%	26.50%	27.64%	25.41%	26.26%	25.09%	24.96%	-21.09%
Net Profit	0.21	0.13	1.77	9.23	5.18	5.44	4.77	5.01	5.87	5.14	4.23	5.35	-5.35
EPS in Rs	0.55	0.34	4.66	24.29	13.63	14.15	12.41	13.03	15.27	13.37	11.01	13.92	-13.92

Last Updated: July 15, 2025, 5:22 pm

Below is a detailed analysis of the quarterly data for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 2.88 Cr.. The value appears to be declining and may need further review. It has decreased from 7.86 Cr. (Dec 2024) to 2.88 Cr., marking a decrease of 4.98 Cr..
For Expenses, as of Mar 2025, the value is 9.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.48 Cr. (Dec 2024) to 9.53 Cr., marking an increase of 9.05 Cr..
For Operating Profit, as of Mar 2025, the value is -6.65 Cr.. The value appears to be declining and may need further review. It has decreased from 7.38 Cr. (Dec 2024) to -6.65 Cr., marking a decrease of 14.03 Cr..
For OPM %, as of Mar 2025, the value is -230.90%. The value appears to be declining and may need further review. It has decreased from 93.89% (Dec 2024) to -230.90%, marking a decrease of 324.79%.
For Other Income, as of Mar 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.68 Cr. (Dec 2024) to 0.53 Cr., marking a decrease of 0.15 Cr..
For Interest, as of Mar 2025, the value is 0.57 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.83 Cr. (Dec 2024) to 0.57 Cr., marking a decrease of 0.26 Cr..
For Depreciation, as of Mar 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.10 Cr. (Dec 2024) to 0.09 Cr., marking a decrease of 0.01 Cr..
For Profit before tax, as of Mar 2025, the value is -6.78 Cr.. The value appears to be declining and may need further review. It has decreased from 7.13 Cr. (Dec 2024) to -6.78 Cr., marking a decrease of 13.91 Cr..
For Tax %, as of Mar 2025, the value is -21.09%. The value appears to be improving (decreasing) as expected. It has decreased from 24.96% (Dec 2024) to -21.09%, marking a decrease of 46.05%.
For Net Profit, as of Mar 2025, the value is -5.35 Cr.. The value appears to be declining and may need further review. It has decreased from 5.35 Cr. (Dec 2024) to -5.35 Cr., marking a decrease of 10.70 Cr..
For EPS in Rs, as of Mar 2025, the value is -13.92. The value appears to be declining and may need further review. It has decreased from 13.92 (Dec 2024) to -13.92, marking a decrease of 27.84.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 23, 2025, 1:56 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	11.34	19.28	38.55	79.19	153.01	1.25	1.58	8.31	13.72	27.36	41.40	25.20
Expenses	11.35	18.86	38.04	76.73	149.43	0.73	0.99	0.75	0.86	1.59	2.82	10.95
Operating Profit	-0.01	0.42	0.51	2.46	3.58	0.52	0.59	7.56	12.86	25.77	38.58	14.25
OPM %	-0.09%	2.18%	1.32%	3.11%	2.34%	41.60%	37.34%	90.97%	93.73%	94.19%	93.19%	56.55%
Other Income	0.04	0.04	-0.19	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	2.32
Interest	0.00	0.38	0.25	1.45	2.27	0.51	2.05	4.29	6.72	4.02	9.78	3.22
Depreciation	0.08	0.11	0.10	0.05	0.04	0.01	0.01	0.01	0.01	0.00	0.08	0.38
Profit before tax	-0.05	-0.03	-0.03	0.96	1.27	0.00	-1.47	3.26	6.12	21.75	28.72	12.97
Tax %	160.00%	-66.67%	-66.67%	18.75%	28.35%	0.00%	0.00%	17.48%	25.65%	25.10%	26.64%	27.76%
Net Profit	-0.13	-0.01	-0.02	0.78	0.90	-0.06	-1.47	2.70	4.57	16.30	21.08	9.38
EPS in Rs	-0.34	-0.03	-0.05	2.05	2.37	-0.16	-3.87	7.11	12.03	42.89	54.85	24.40
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.82%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	92.31%	-100.00%	4000.00%	15.38%	-106.67%	-2350.00%	283.67%	69.26%	256.67%	29.33%	-55.50%
Change in YoY Net Profit Growth (%)	0.00%	-192.31%	4100.00%	-3984.62%	-122.05%	-2243.33%	2633.67%	-214.41%	187.41%	-227.35%	-84.83%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	3%
5 Years:	74%
3 Years:	22%
TTM:	-39%

Compounded Profit Growth
10 Years:	78%
5 Years:	53%
3 Years:	27%
TTM:	-56%

Stock Price CAGR
10 Years:	%
5 Years:	141%
3 Years:	30%
1 Year:	-19%

Return on Equity
10 Years:	22%
5 Years:	26%
3 Years:	25%
Last Year:	10%

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 12:59 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.42	3.42	3.42	3.42	3.42	3.42	3.42	3.42	3.42	3.42	3.84	3.84
Reserves	4.76	4.75	4.73	5.51	6.41	6.47	4.98	7.62	12.06	28.37	89.76	98.77
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	248.84	0.00	0.00
Other Liabilities	0.05	0.01	0.03	0.24	0.40	0.05	0.27	0.82	0.02	28.57	20.02	19.83
Total Liabilities	8.23	8.18	8.18	9.17	10.23	9.94	8.67	11.86	15.50	309.20	113.62	122.44
Fixed Assets	0.38	0.24	0.14	0.09	0.06	0.05	0.05	0.06	0.00	0.00	1.14	0.80
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.00	0.00	0.00	0.00	7.90	3.82	6.85	13.52	0.05	12.24	73.07
Other Assets	7.84	7.94	8.04	9.08	10.17	1.99	4.80	4.95	1.98	309.15	100.24	48.57
Total Assets	8.23	8.18	8.18	9.17	10.23	9.94	8.67	11.86	15.50	309.20	113.62	122.44

Below is a detailed analysis of the balance sheet data for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 3.84 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.84 Cr..
For Reserves, as of Mar 2025, the value is 98.77 Cr.. The value appears strong and on an upward trend. It has increased from 89.76 Cr. (Mar 2024) to 98.77 Cr., marking an increase of 9.01 Cr..
For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 19.83 Cr.. The value appears to be improving (decreasing). It has decreased from 20.02 Cr. (Mar 2024) to 19.83 Cr., marking a decrease of 0.19 Cr..
For Total Liabilities, as of Mar 2025, the value is 122.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 113.62 Cr. (Mar 2024) to 122.44 Cr., marking an increase of 8.82 Cr..
For Fixed Assets, as of Mar 2025, the value is 0.80 Cr.. The value appears to be declining and may need further review. It has decreased from 1.14 Cr. (Mar 2024) to 0.80 Cr., marking a decrease of 0.34 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Mar 2025, the value is 73.07 Cr.. The value appears strong and on an upward trend. It has increased from 12.24 Cr. (Mar 2024) to 73.07 Cr., marking an increase of 60.83 Cr..
For Other Assets, as of Mar 2025, the value is 48.57 Cr.. The value appears to be declining and may need further review. It has decreased from 100.24 Cr. (Mar 2024) to 48.57 Cr., marking a decrease of 51.67 Cr..
For Total Assets, as of Mar 2025, the value is 122.44 Cr.. The value appears strong and on an upward trend. It has increased from 113.62 Cr. (Mar 2024) to 122.44 Cr., marking an increase of 8.82 Cr..

Notably, the Reserves (98.77 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	-2.61	-0.44	-0.39	4.39	-1.40	-0.91	-3.92	-5.36	-0.16	-259.39	258.09	32.03
Cash from Investing Activity +	0.94	0.46	1.20	0.37	0.21	1.20	5.39	3.88	6.74	14.08	-12.09	-59.04
Cash from Financing Activity +	0.00	-0.38	-0.25	-1.45	-2.28	0.00	0.00	0.00	-6.72	245.58	-217.58	-1.13
Net Cash Flow	-1.67	-0.37	0.57	3.31	-3.47	0.29	1.47	-1.48	-0.13	0.26	28.42	-28.14

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-0.01	0.42	0.51	2.46	3.58	0.52	0.59	7.56	12.86	-223.07	38.58	14.25

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	30.58	0.19	0.00	0.46	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Days	106.39	97.69	50.19	12.78	19.49
Days Payable	0.00	0.00	0.10	0.00	0.00
Cash Conversion Cycle	136.96	97.88	50.09	13.24	19.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Working Capital Days	180.57	118.51	62.49	18.30	19.80	195.64	32.34	52.71	19.95	-352.73	-166.98	-264.77
ROCE %	-0.61%	4.04%	5.27%	28.22%	37.74%	5.17%	6.34%	77.67%	96.91%	17.41%	20.58%	16.50%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Promoters	83.66%	83.66%	83.66%	74.36%	74.36%	74.36%	74.36%	74.36%	74.36%	74.36%	74.36%	74.36%
FIIs	0.00%	0.00%	0.06%	4.26%	4.26%	4.26%	4.26%	4.26%	4.26%	4.26%	4.26%	4.26%
Public	16.35%	16.35%	16.29%	21.38%	21.39%	21.39%	21.38%	21.39%	21.38%	21.39%	21.39%	21.39%
No. of Shareholders	1,355	1,612	2,098	2,418	2,913	3,114	2,916	3,357	3,633	3,902	4,033	3,958

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23
FaceValue	10.00	10.00	10.00
Basic EPS (Rs.)	24.69	55.46	47.91
Diluted EPS (Rs.)	24.69	55.46	47.91
Cash EPS (Rs.)	25.67	55.29	47.91
Book Value[Excl.RevalReserv]/Share (Rs.)	267.70	243.95	93.22
Book Value[Incl.RevalReserv]/Share (Rs.)	267.70	243.95	93.22
Revenue From Operations / Share (Rs.)	65.57	101.54	79.99
PBDIT / Share (Rs.)	43.50	100.71	75.66
PBIT / Share (Rs.)	42.52	100.50	75.66
PBT / Share (Rs.)	34.15	75.05	63.94
Net Profit / Share (Rs.)	24.69	55.09	47.91
NP After MI And SOA / Share (Rs.)	24.69	55.09	47.91
PBDIT Margin (%)	66.34	99.18	94.58
PBIT Margin (%)	64.85	98.98	94.58
PBT Margin (%)	52.08	73.91	79.93
Net Profit Margin (%)	37.65	54.25	59.89
NP After MI And SOA Margin (%)	37.65	54.25	59.89
Return on Networth / Equity (%)	9.22	22.58	51.39
Return on Capital Employeed (%)	13.38	40.69	77.73
Return On Assets (%)	6.74	16.21	5.01
Total Debt / Equity (X)	0.00	0.00	7.81
Asset Turnover Ratio (%)	0.18	0.17	0.00
Current Ratio (X)	6.21	3.22	1.06
Quick Ratio (X)	6.21	3.22	1.06
Interest Coverage Ratio (X)	5.19	3.96	6.46
Interest Coverage Ratio (Post Tax) (X)	3.95	3.16	5.09
Enterprise Value (Cr.)	518.00	588.14	630.60
EV / Net Operating Revenue (X)	20.55	15.07	23.07
EV / EBITDA (X)	30.98	15.20	24.40
MarketCap / Net Operating Revenue (X)	20.78	15.91	14.11
Price / BV (X)	5.09	6.62	12.11
Price / Net Operating Revenue (X)	20.78	15.91	14.11
EarningsYield	0.01	0.03	0.04

After reviewing the key financial ratios for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 24.69. This value is within the healthy range. It has decreased from 55.46 (Mar 24) to 24.69, marking a decrease of 30.77.
For Diluted EPS (Rs.), as of Mar 25, the value is 24.69. This value is within the healthy range. It has decreased from 55.46 (Mar 24) to 24.69, marking a decrease of 30.77.
For Cash EPS (Rs.), as of Mar 25, the value is 25.67. This value is within the healthy range. It has decreased from 55.29 (Mar 24) to 25.67, marking a decrease of 29.62.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 267.70. It has increased from 243.95 (Mar 24) to 267.70, marking an increase of 23.75.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 267.70. It has increased from 243.95 (Mar 24) to 267.70, marking an increase of 23.75.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 65.57. It has decreased from 101.54 (Mar 24) to 65.57, marking a decrease of 35.97.
For PBDIT / Share (Rs.), as of Mar 25, the value is 43.50. This value is within the healthy range. It has decreased from 100.71 (Mar 24) to 43.50, marking a decrease of 57.21.
For PBIT / Share (Rs.), as of Mar 25, the value is 42.52. This value is within the healthy range. It has decreased from 100.50 (Mar 24) to 42.52, marking a decrease of 57.98.
For PBT / Share (Rs.), as of Mar 25, the value is 34.15. This value is within the healthy range. It has decreased from 75.05 (Mar 24) to 34.15, marking a decrease of 40.90.
For Net Profit / Share (Rs.), as of Mar 25, the value is 24.69. This value is within the healthy range. It has decreased from 55.09 (Mar 24) to 24.69, marking a decrease of 30.40.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.69. This value is within the healthy range. It has decreased from 55.09 (Mar 24) to 24.69, marking a decrease of 30.40.
For PBDIT Margin (%), as of Mar 25, the value is 66.34. This value is within the healthy range. It has decreased from 99.18 (Mar 24) to 66.34, marking a decrease of 32.84.
For PBIT Margin (%), as of Mar 25, the value is 64.85. This value exceeds the healthy maximum of 20. It has decreased from 98.98 (Mar 24) to 64.85, marking a decrease of 34.13.
For PBT Margin (%), as of Mar 25, the value is 52.08. This value is within the healthy range. It has decreased from 73.91 (Mar 24) to 52.08, marking a decrease of 21.83.
For Net Profit Margin (%), as of Mar 25, the value is 37.65. This value exceeds the healthy maximum of 10. It has decreased from 54.25 (Mar 24) to 37.65, marking a decrease of 16.60.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 37.65. This value exceeds the healthy maximum of 20. It has decreased from 54.25 (Mar 24) to 37.65, marking a decrease of 16.60.
For Return on Networth / Equity (%), as of Mar 25, the value is 9.22. This value is below the healthy minimum of 15. It has decreased from 22.58 (Mar 24) to 9.22, marking a decrease of 13.36.
For Return on Capital Employeed (%), as of Mar 25, the value is 13.38. This value is within the healthy range. It has decreased from 40.69 (Mar 24) to 13.38, marking a decrease of 27.31.
For Return On Assets (%), as of Mar 25, the value is 6.74. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 6.74, marking a decrease of 9.47.
For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has increased from 0.17 (Mar 24) to 0.18, marking an increase of 0.01.
For Current Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 3. It has increased from 3.22 (Mar 24) to 6.21, marking an increase of 2.99.
For Quick Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 2. It has increased from 3.22 (Mar 24) to 6.21, marking an increase of 2.99.
For Interest Coverage Ratio (X), as of Mar 25, the value is 5.19. This value is within the healthy range. It has increased from 3.96 (Mar 24) to 5.19, marking an increase of 1.23.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.95. This value is within the healthy range. It has increased from 3.16 (Mar 24) to 3.95, marking an increase of 0.79.
For Enterprise Value (Cr.), as of Mar 25, the value is 518.00. It has decreased from 588.14 (Mar 24) to 518.00, marking a decrease of 70.14.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 20.55. This value exceeds the healthy maximum of 3. It has increased from 15.07 (Mar 24) to 20.55, marking an increase of 5.48.
For EV / EBITDA (X), as of Mar 25, the value is 30.98. This value exceeds the healthy maximum of 15. It has increased from 15.20 (Mar 24) to 30.98, marking an increase of 15.78.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 20.78. This value exceeds the healthy maximum of 3. It has increased from 15.91 (Mar 24) to 20.78, marking an increase of 4.87.
For Price / BV (X), as of Mar 25, the value is 5.09. This value exceeds the healthy maximum of 3. It has decreased from 6.62 (Mar 24) to 5.09, marking a decrease of 1.53.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 20.78. This value exceeds the healthy maximum of 3. It has increased from 15.91 (Mar 24) to 20.78, marking an increase of 4.87.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of July 31, 2025 is: 1,444.57

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 31, 2025, is Overvalued by 16.26% compared to the current share price 1,725.00

Intrinsic Value of as of July 31, 2025 is: 1,848.60

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 31, 2025, is Undervalued by 7.17% compared to the current share price 1,725.00

Last 5 Year EPS CAGR: 27.97%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 26.27%, which is a positive sign. The stock has a low average Working Capital Days of -7.01, which is a positive sign. The company has higher reserves (22.85 cr) compared to borrowings (20.74 cr), indicating strong financial stability. The company has shown consistent growth in sales (35.02 cr) and profit (6.12 cr) over the years.	The stock has a high average Cash Conversion Cycle of 26.49, which may not be favorable.

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
1. Net Profit Margin: 37.65%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 13.38% (Industry Average ROCE: 21.18%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.22% (Industry Average ROE: 13.3%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.95
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 6.21
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 70.7 (Industry average Stock P/E: 80.99)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Mkventures Capital Ltd. is a Public Limited Listed company incorporated on 17/01/1991 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L17100MH1991PLC059848 and registration number is 059848. Currently Company is involved in the business activities of Other financial service activities, except insurance and pension funding activities. Company's Total Operating Revenue is Rs. 25.20 Cr. and Equity Capital is Rs. 3.84 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Finance & Investments	11th Floor, Express Towers, Mumbai Maharashtra 400021	info@mkventurescapital.com http://www.mkventurescapital.com

Management
Name	Position Held
Mr. Madhusudan Murlidhar Kela	Managing Director
Mr. Sumit Bhalotia	Non Executive Director
Mr. Sanjay Malpani	Independent Director
Mr. Siddharth Agarwal	Independent Director
Mr. Rajeev Agarwal	Independent Director
Mrs. Shruti Bahety	Independent Director

FAQ

What is the intrinsic value of ?

's intrinsic value (as of 31 July 2025) is 1444.57 16.26% lower the current market price of 1,725.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 663 Cr. market cap, FY2025-2026 high/low of 2,400/1,151, reserves of 98.77 Cr, and liabilities of 122.44 Cr.

What is the Market Cap of ?

The Market Cap of is 663 Cr..

What is the current Stock Price of as on 31 July 2025?

The current stock price of as on 31 July 2025 is 1,725.

What is the High / Low of stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of stocks is ₹2,400/1,151.

What is the Stock P/E of ?

The Stock P/E of is 70.7.

What is the Book Value of ?

The Book Value of is 267.

What is the Dividend Yield of ?

The Dividend Yield of is 0.06 %.

What is the ROCE of ?

The ROCE of is 16.5 %.

What is the ROE of ?

The ROE of is 9.56 %.

What is the Face Value of ?

The Face Value of is 10.0.